Phibro Animal Health (PAHC) Reports In-Line Q3 EPS, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports Third Quarter and Year-to-Date Results
May 6, 2021 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced financial results for its third quarter and year-to-date period ended March 31, 2021.
Highlights for the March 31, 2021 quarter (compared to the quarter ended March 31, 2020)
Net sales of $212 million, an increase of $1 million, or less than 1% Net income of $12 million, a decrease of $1 million, or 10% Diluted EPS of $0.30, a decrease of $0.03, or 9% Adjusted EBITDA of $28 million, a decrease of $2 million, or 7% Adjusted Net Income of $14 million, a decrease of $2 million, or... More


